Analysis of the data from the Kaplan–Meier Plotter confirmed that tumor GRP75 expression could predict the survival of patients with breast cancer, lung adenocarcinoma, and liver hepatocellular carcinoma (Figure 3K).[27, 28] A correlation analysis showed that GRP75 expression was significantly associated with patient age, differentiation, and survival (Table S4, Supporting Information). The gene discussed is HSPA9; the disease is lung adenocarcinoma.